ValiRx (LSE:VAL) Days Sales Outstanding : 257.33 (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is ValiRx Days Sales Outstanding?

ValiRx's average Accounts Receivable for the six months ended in Dec. 2024 was £0.07 Mil. ValiRx's Revenue for the six months ended in Dec. 2024 was £0.05 Mil. Hence, ValiRx's Days Sales Outstanding for the six months ended in Dec. 2024 was 257.33.

The historical rank and industry rank for ValiRx's Days Sales Outstanding or its related term are showing as below:

LSE:VAL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 112.14 Med: 209.37 Max: 514.65
Current: 514.65

During the past 13 years, ValiRx's highest Days Sales Outstanding was 514.65. The lowest was 112.14. And the median was 209.37.

LSE:VAL's Days Sales Outstanding is ranked worse than
94.1% of 848 companies
in the Biotechnology industry
Industry Median: 70.36 vs LSE:VAL: 514.65

ValiRx's Days Sales Outstanding declined from Dec. 2023 (3,668.25) to Dec. 2024 (257.33).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

ValiRx Days Sales Outstanding Historical Data

The historical data trend for ValiRx's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ValiRx Days Sales Outstanding Chart

ValiRx Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

306.60

ValiRx Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	3,668.25	-	257.33

Competitive Comparison of ValiRx's Days Sales Outstanding

For the Biotechnology subindustry, ValiRx's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ValiRx's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ValiRx's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ValiRx's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

ValiRx Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ValiRx's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0.042)	/	1 )	/	0.05	*	365
=	0.042					/	0.05	*	365
=	306.60

ValiRx's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.099	+	0.042)	/	2 )	/	0.05	*	365 / 2
=	0.0705					/	0.05	*	365 / 2
=	257.33

ValiRx (LSE:VAL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ValiRx Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ValiRx's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ValiRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

EAJF:Germany

Address

D6 Thane Road, MediCity Nottingham, Nottingham, GBR, NG90 6BH

Website

https://www.valirx.com

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, VAL401 for lung cancer, VAL301, BC201, CLX001, and other drug candidates in their different stages of development.